SCHEMBL30210909

SCHEMBL30210909

C[C@H](C(N)=O)N(c1ccc(F)cc1)c1nc(N)c(C(=O)c2cc(C(=O)NCC3CC3)no2)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.38
POLB P06746 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MLLT1 Q03111 1/20 0.36
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
THRB P10828 1/20 0.34
RAB9A P51151 1/20 0.34
GABRA5 P31644 2/20 0.33
ADORA2A P29274 2/20 0.33
ADORA2B P29275 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
TSHR P16473 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930575 1.00 HIF1A (0.38) HIF1APOLBSMN1; SMN2MLLT1MAPT
SCHEMBL30210868 0.89 NPC1 (0.41) POLBSMN1; SMN2MAPTKMT2AMEN1
SCHEMBL23930487 0.89 NPC1 (0.41) POLBSMN1; SMN2MAPTKMT2AMEN1
SCHEMBL31411943 0.88 SMN1; SMN2 (0.38) HIF1APOLBSMN1; SMN2MAPTKMT2A
SCHEMBL25199172 0.88 SMN1; SMN2 (0.38) HIF1APOLBSMN1; SMN2MAPTKMT2A
SCHEMBL23930566 0.88 SMN1; SMN2 (0.37) HIF1APOLBSMN1; SMN2MAPTKMT2A
SCHEMBL30210930 0.88 SMN1; SMN2 (0.37) HIF1APOLBSMN1; SMN2MAPTKMT2A
SCHEMBL23930596 0.88 POLB (0.37) HIF1APOLBSMN1; SMN2MAPTKMT2A
SCHEMBL30210895 0.88 POLB (0.37) HIF1APOLBSMN1; SMN2MAPTKMT2A
SCHEMBL25547090 0.87 SMN1; SMN2 (0.35) HIF1APOLBSMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4139287-B1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AG (DE) 2025-02-26 EP claimed
EP-4139287-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION Bayer Aktiengesellschaft (DE) 2023-03-01 EP claimed
EP-4139287-B1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AG (DE) 2025-02-26 EP disclosed